SÜSS MicroTec SE

Quarterly Report • May 11, 2023

QUARTERLY REPORT JANUARY 1 – MARCH 31,

KEY FIGURES

in € million	Q1 2023	Q1 2022	Change
Business development
Order entry	99.6	117.6	-15.3%
Order backlog as of 03/31	373.2	249.2	49.8%
Sales	70.4	63.3	11.2%
Gross profit	23.3	21.0	10.8%
Gross profit margin	33.1%	33.2%	-0.1% points
Cost of sales	47.1	42.3	11.3%
Research and development costs	8.8	6.2	41.9%
EBITDA	5.4	4.2	28.6%
EBITDA margin	7.7%	6.6%	1.1% points
EBIT	2.9	2.1	38.1%
EBIT margin	4.1%	3.3%	0.8% points
Earnings after taxes	2.1	1.4	50.0%
Earnings per share, undiluted (in EUR)	0.11	0.07	57.2%

in € million	Q1 2023	Q1 2022	Change
Statement of financial position and cash flows
Shareholders' equity	179.0	158.8	12.7%
Equity ratio	51.6%	55.2%	-3.6% points
Total assets	347.1	287.8	20.6%
Net cash	41.0	35.2	16.5%
Free cash flow	0.3	1.6	-81.3%
Further key figures
Investments	1.6	1.4	14.3%
Investment ratio	2.2%	2.2%	0.0% points
Depreciation and amortization	2.4	2.1	14.3%
Employees as of 03/31	1,261	1,194	5.6%

CONTENTS

Business Development in the First Quarter of 2023…..4

	Financial Report……………………………………………10
--	-------------------------------------	--

Consolidated Statement of Income (IFRS)	10
Statement of Comprehensive Income (IFRS)	11
Consolidated Statement of Financial Position (IFRS)	12
Consolidated Statement of Cash Flows (IFRS)	13
Consolidated Statement of Changes in Equity (IFRS)	15
Segment Reporting (IFRS)	16

Financial Calendar/Contact/Imprint…………………….17

DR. BERND SCHULTE, CHIEF EXECUTIVE OFFICER OF SÜSS MICROTEC SE:

"In terms of the investment readiness of many semiconductor manufacturers, various industry experts anticipated a subdued first half of 2023. For this reason, we are all more than pleased with our strong order entry of nearly EUR 100 million. We increased our sales by 11.2 percent. Unfortunately, we have not yet succeeded in sustainably improving the gross profit margin and EBIT margin year-on-year. In view of the product mix in the order backlog and the growing volume, we expect the margin to improve over the course of the year and therefore confirm our forecast for the full year 2023."

BUSINESS DEVELOPMENT IN THE FIRST QUARTER OF 2023

In the first quarter of 2023, we succeeded in significantly increasing order entry compared with the EUR 72.8 million of the fourth quarter of 2022. Contrary to different industry experts, who expected restraint in the willingness to invest of semiconductor manufacturers, particularly in the first half of 2023, we consider our order entry of EUR 99.6 million to be a very positive figure. Compared to the especially strong opening quarter in the 2022 fiscal year, new business was down 15.3 percent. The newly created Advanced Backend Solutions division, which since this fiscal year has combined the previously separate Lithography and Bonder divisions, accounted for more than 50 percent of order entry at EUR 56.2 million. While the Photomask Solutions division (formerly: Photomask Equipment) recorded an almost stable order situation, new business in the MicroOptics division declined. In regional terms, the Asia region again contributed the largest share of order entry, accounting for more than 70 percent.

We increased our sales by 11.2 percent to EUR 70.4 million in the first quarter of 2023 (previous year: EUR 63.3 million), thus continuing our growth trend. Supply bottlenecks for purchased parts and components continue to affect our production and delivery times.

The order backlog thus grew to EUR 373.2 million and at the end of the first quarter was 49.8 percent above the level of the previous year (EUR 249.2 million).

In the first quarter, gross profit increased by EUR 2.3 million or 10.8 percent to EUR 23.3 million. The gross profit margin was 33.1 percent (previous year: 33.2 percent) and thus below the targeted margin for the full year. This was primarily attributable to the unsatisfactory margin development in our bonder business and the MicroOptics division. In each of these divisions, the gross profit margin was below 25 percent, largely due to an unfavorable product mix. Only our lithography solutions met our expectations with a gross margin of almost 40 percent.

In our selling, administration, and development costs, we made a change to the cost reporting for our application laboratories as of the beginning of 2023. These costs were included in selling costs in the past, but are now shown in research and development expenses. This change is expected to have an effect of around EUR 6 million in the full year 2023. In the first quarter, the effect amounted to EUR 1.1 million. Overall, research and development expenses increased by EUR 2.6 million in the first three months. In contrast, selling costs decreased by EUR 1.0 million due to the change in the reporting of application costs from selling costs to research and development costs. Due to increased IT and personnel costs, administrative costs were EUR 1.2 million higher than in the first quarter of the previous year. In total, selling, administrative, and development costs amounted to EUR 20.6 million (previous year: EUR 17.9 million). Meanwhile, a positive effect of EUR 1.3 million resulted from the balance of other operating income and expenses. This improvement was primarily due to a positive effect of EUR 0.2 million (previous year: EUR -0.8 million) from foreign currency valuation.

Overall, EBIT in the first quarter of 2023 increased by EUR 0.8 million or around 38 percent to EUR 2.9 million (previous year: EUR 2.1 million). The quarterly earnings corresponded to an EBIT margin of 4.1 percent (previous year: 3.3 percent). Earnings after taxes increased to EUR 2.1 million (previous year: EUR 1.4 million). Basic earnings per share (EPS) amounted to EUR 0.11 (previous year: EUR 0.07).

Free cash flow amounted to EUR 0.3 million in the first three months of the current fiscal year (previous year: EUR 1.6 million). The further increase in advance payments from our customers was unable to compensate for the increase in inventory reserves. The net cash position improved from EUR 35.2 million as of March 31, 2022 to EUR 41.0 million as of March 31, 2023.

Merging of the Lithography and Bonder divisions

The previously separate Lithography and Bonder divisions produce typical products for manufacturing processes in the semiconductor industry in the middle-end-of-line and end-of-line areas. They serve the same markets and customers. In addition, the products are sold through the joint sales structure. The production processes are partially linked. Starting in the 2023 fiscal year, we will combine the Lithography and Bonder divisions in the newly formed Advanced Backend Solutions division, thus changing the division structure. The following description of business development is based on the new divisions Advanced Backend Solutions, Photomask Solutions (formerly Photomask Equipment), MicroOptics, and Central Group Functions (formerly Others). For comparison purposes, we will still report the development of order entry and sales for the former Lithography and Bonder divisions in the division reporting for the 2023 fiscal year.

BUSINESS DEVELOPMENT IN THE INDIVIDUAL DIVISIONS

Advanced Backend Solutions division

The newly created Advanced Backend Solutions division comprises the two former divisions Lithography and Bonder. This division includes the development, manufacture, and sale of the bonder, mask aligner, UV projection scanner and coater/developer product lines, nanoimprint equipment, and machines for inkjet-based coating processes (inkjet processes). These product lines are manufactured in Germany at the locations in Garching, near Munich, and in Sternenfels, as well as at the Hsinchu location in Taiwan. The primary target market for this division is the advanced backend of the semiconductor industry.

_______________________________________________________

Advanced Backend Solutions Key Figures

in € million	Q1 2023	Q1 2022
Order entry:	56.2	69.5
- Of which lithography	44.8	49.4
- Of which bonders	11.4	20.1
Total Sales:*	41.0	45.5
- Of which lithography	32.6	33.4
- Of which bonders	8.4	12.1
Gross profit	14.9	15.9
Gross profit margin*	36.3%	34.9%
EBIT	0.7	3.5
EBIT margin*	1.7%	7.7%

*Total sales include internal sales (sales to other divisions). The gross profit margin and EBIT margin are calculated based on total sales.

In the first quarter of 2023, we recorded order entry of EUR 56.2 million (previous year: EUR 69.5 million). The main reason for the decline was lower demand for our bonders compared with the previous year. The result was a decrease in order entry from EUR 20.1 million to EUR 11.4 million. In addition, demand for coaters/developers was slightly lower in the past quarter. On the other hand, mask aligners reported a slight increase in order entry. It should be noted that the order entry in the first quarter of 2022 included a mid-single-digit million euro amount for UV projection scanners. This was not the case in the first quarter of 2023.

At EUR 41.0 million, division sales were down EUR 4.5 million or 9.9 percent from the previous year's figure of EUR 45.5 million, due in particular to a year-on-year decline of nearly EUR 4 million in sales of bonders. There was a lack of sales contributions from fully automated permanent bonders, which accounted for a significant share of sales in the prior-year quarter. Sales of coaters/developers and mask aligners were only slightly down from the previous year.

The gross profit margin in the Advanced Backend Solutions division improved slightly from 34.9 percent to 36.3 percent thanks to the overall higher share of sales from high-margin lithography equipment.

Despite the slight improvement in the gross margin, division earnings decreased from EUR 3.5 million to EUR 0.7 million, resulting in an EBIT margin of 1.7 percent, compared with 7.7 percent in the previous year. The decline in earnings was attributable to several factors. The main reason was the strongly negative EBIT margin in the former Bonder division, where gross profit was significantly lower. In addition, division expenses, such as for research and development, increased in the first quarter of 2023. This is an investment in the future of the area, especially in regard to hybrid bonding. This was offset by a reduction

in selling costs of around EUR 1.4 million. The main reason for these two offsetting effects is the previously described change in the presentation of costs for the application from selling costs to research and development costs.

Photomask Solutions division

The Photomask Solutions division, located at the Sternenfels site, comprises the development, manufacture, and sale of systems for cleaning and processing photomasks for the semiconductor industry. This is the only division in which SUSS MicroTec is active on the front end.

_______________________________________________________

Photomask Solutions Key Figures

in € million	Q1 2023	Q1 2022
Order entry	38.6	40.9
Total Sales*	23.1	7.8
Gross profit	7.0	2.1
Gross profit margin*	30.3%	26.9%
EBIT	3.7	-1.4
EBIT margin*	16.0%	-17.9%

*Total sales include internal sales (sales to other divisions). The gross profit margin and EBIT margin are calculated based on total sales.

At EUR 38.6 million, order entry in the Photomask Solutions division was at a similarly high level to the previous year (EUR 40.9 million). Sales in this division developed very positively at the beginning of the year, almost tripling from EUR 7.8 million in the previous year to EUR 23.1 million. The increase was mainly due to the high order backlog and continued positive demand from Asia.

Meanwhile, the gross profit margin increased from 26.9 percent to 30.3 percent in the first quarter. This increase was due to higher overall division sales and a more favorable product mix.

Due to the positive sales development and despite increased research, development, and administrative expenses, the division earnings increased significantly from EUR -1.4 million to EUR 3.7 million. The EBIT margin thus reached 16.0 percent, compared with -17.9 percent in the previous year.

MicroOptics division

The MicroOptics division comprises the activities of the SUSS MicroOptics subsidiary at the Hauterive location in Switzerland. The production and sales of microlenses and highly specialized optics for the automotive industry and a variety of industrial applications are located here.

_______________________________________________________

MicroOptics Key Figures

in € million	Q1 2023	Q1 2022
Order entry	4.7	7.1
Total Sales*	6.9	10.6
Gross profit	1.4	3.1
Gross profit margin*	20.3%	29.2%
EBIT	-1.1	0.7
EBIT margin*	-15.9%	6.6%

*Total sales include internal sales (sales to other divisions). The gross profit margin and EBIT margin are calculated based on total sales.

Order entry in the MicroOptics division declined in the first quarter of 2023 and at EUR 4.7 million was 33.9 percent below the previous year's figure of EUR 7.1 million. Sales also fell significantly in the first three months to EUR 6.9 million (previous year: EUR 10.6 million). The declines in order entry and sales were due in particular to price concessions for customers in the automotive industry in order to secure production volumes and capacity utilization. At the same time, the industrial optics business was characterized by restraint.

The high level of competition in the automotive business and the price concessions described above had a negative impact on the gross profit margin. It decreased significantly from 29.2 percent to an unsatisfactory 20.3 percent. The division earnings fell year-on-year from EUR 0.7 million to EUR -1.1 million.

Central Group Functions

The Central Group Functions division represents all other activities as well as costs for central Group functions that generally cannot be attributed to the main divisions. The division posted slightly negative EBIT of EUR -0.3 million in the first three months of 2023 (previous year: EUR -0.7 million).

OUTLOOK

SUSS MicroTec again succeeded in generating a strong order entry in the first three months of 2023, which was significantly above the general market expectation. The substantial growth in orders in the past quarter is attributable to the successful expansion of our business relationships with existing key accounts and the acquisition of relevant new customers, particularly in the Photomask Solutions and Advanced Backend Solutions divisions. We are generally confident about the further trajectory of demand. Negative effects due to geopolitical conflicts, particularly Russia's war of aggression on Ukraine, and uncertain interest rate and inflation developments are still possible.

The high order backlog of EUR 373.2 million at the end of the first quarter and the continuing positive orders position continue to provide a very good basis for our targeted growth. If the currently still existing supply shortages and the overall global economic situation, particularly in the semiconductor and semiconductor equipment markets, do not deteriorate unexpectedly during the 2023 fiscal year, we still expect sales to range from EUR 320 million to EUR 360 million for the full year of 2023. At the midpoint of the range, this would correspond to growth of 13.7 percent. Due to the high order backlog and high capacity utilization, we will not be able to deliver and recognize in sales most of the new orders received in the 2023 fiscal year until the 2024 fiscal year.

We are currently in discussions with our customers to respond to ongoing cost increases by implementing price increases for our solutions. However, the sales and earnings impact will be delayed due to delivery times of several months. SUSS MicroTec is largely protected from significant increases in energy costs because it has long-term gas and electricity supply contracts for the German sites that run until 2024 and 2025. Higher personnel costs due to recruitment and salary increases in the 2023 fiscal year had a negative impact on the earnings situation. Overall, we expect the higher level of sales and the associated economies of scale to lead to an improvement in earnings before interest and income taxes (EBIT). For the full year 2023, we continue to expect an EBIT margin in the range of 10 to 12 percent.

Since the beginning of the 2023 fiscal year, we have been reporting gross margin as our third key performance indicator. The gross margin may vary considerably from quarter to quarter because it is significantly influenced by the product mix (i.e., the composition of the equipment delivered and recognized in sales) and the customer mix. Despite the still unsatisfactory gross margin of 33.1 percent in the opening quarter, we expect the gross margin for the full year 2023 to be in the range of 37 to 38 percent in view of the order backlog and the product mix of the equipment deliveries planned for 2023. We thus confirm the forecast for all three key performance indicators for the current fiscal year.

Garching, May 2023

Dr. Bernd Schulte Dr. Thomas Rohe Chief Executive Officer (CEO) Chief Operations Officer (COO)

FINANCIAL REPORT – CONSOLIDATED INCOME STATEMENT (IFRS)

in € thousand	01/01/2023 – 03/31/2023	01/01/2022 – 03/31/2022
Sales	70,376	63,317
Cost of sales	-47,117	-42,283
Gross profit from sales	23,259	21,034
Selling costs	-5,023	-6,070
Research and development costs	-8,791	-6,213
Administration costs	-6,834	-5,663
Other operating income	1,909	1,369
Other operating expenses	-1,571	-2,347
Analysis of net income from operations (EBIT):
EBITDA (earnings before interest and taxes, depreciation, and amortization)	5,382	4,543
Depreciation and amortization of tangible assets, intangible assets and financial assets	-2,433	-2,433
Net income from operations (EBIT)	2,949	2,110
Financial income	69	2
Financial expenses	-85	-133
Financial result	-16	-131
Profit before taxes	2,933	1,979
Income taxes	-829	-559
Profit	2,104	1,420
Of which equity holders of SUSS MicroTec	2,104	1,420
Earnings per share (undiluted)
Earnings per share in EUR	0.11	0.07
Earnings per share (diluted)
Earnings per share in EUR	0.11	0.07

STATEMENT OF COMPREHENSIVE INCOME (IFRS)

in € thousand	01/01/2023 – 03/31/2023	01/01/2022 – 03/31/2022
Profit for the period	2,104	1,420
Items that will not be reclassified to profit and loss
Revaluation of defined benefit pension plans	0	0
Deferred taxes	0	0
Other earnings after taxes for items that will not be reclassified to profit and loss	0	0
Items that will be reclassified to profit and loss in later periods
Foreign currency adjustment	-810	519
Cash flow hedges	0	0
Deferred taxes	0	0
Other earnings after taxes for items that will be reclassified to profit and loss in later periods	-810	519
Total income and expenses recognized in shareholders' equity	-810	519
Total income and expenses reported in the reporting period	1,294	1,939
Of which equity holders of SUSS MicroTec	1,294	1,939
Of which non-controlling interests	0	0

CONSOLIDATED STATEMENT OF FINANCIAL POSITION (IFRS)

03/31/2023	12/31/2022
74,317	75,140
5,724	5,875
18,535	18,574
48,333	48,869
402	417
1,323	1,405
272,814	278,022
162,005	150,537
17,240	19,096
23,959	37,880
376	638
9,914	9,943
58	58
50,493	51,364
8,769	8,506
347,131	353,162

in € thousand	03/31/2023	12/31/2022
EQUITY AND LIABILITIES
Shareholders' equity	179,024	177,730
Total shareholders' equity attributable to shareholders of SÜSS MicroTec SE	179,024	177,730
Subscribed capital	19,116	19,116
Reserves	158,554	156,450
Accumulated other comprehensive income	1,354	2,164
Noncurrent liabilities	32,285	32,807
Pension plans and similar commitments	5,045	5,032
Provisions	776	776
Financial debt to banks	6,250	6,563
Financial debt from lease obligations	9,125	9,627
Other liabilities	250	264
Deferred tax liabilities	10,839	10,545
Current liabilities	135,822	142,625
Provisions	4,658	5,951
Tax liabilities	6,743	7,024
Financial debt to banks	1,226	1,226
Financial debt from lease obligations	2,822	2,588
Other financial liabilities	12,389	11,989
Trade payables	20,978	27,091
Contract liabilities	77,777	77,939
Other liabilities	9,229	8,817
Total assets	347,131	353,162

CONSOLIDATED STATEMENT OF CASH FLOWS (IFRS)

in € thousand	01/01/2023 – 03/31/2023	01/01/2022 – 03/31/2022
Net profit or loss (after taxes)	2,104	1,420
Amortization of intangible assets	371	218
Depreciation of tangible assets	2,065	1,917
Profit or loss on disposal of intangible and tangible assets	66	0
Change in value adjustment on inventory reserves	1,138	1,350
Change in value adjustment on trade receivables	9	1,640
Non-cash income from the reversal of pension provisions	0	0
Other non-cash effective income and expenses	-188	214
Change in inventory reserves	-12,851	-16,459
Change in contract assets	13,917	7,973
Change in trade receivables	1,718	-3,245
Change in other assets	14	2,841
Change in provisions for pensions	63	68
Change in trade payables	-6,073	-4,495
Change in contract liabilities	-96	11,524
Change in other liabilities and other provisions	-475	906
Change in tax assets and current tax liabilities	95	-2,844
Cash flow from operating activities	1,877	3,028

in € thousand	01/01/2023 – 03/31/2023	01/01/2022 – 03/31/2022
Disbursements for tangible assets	-1,341	-1,173
Disbursements for intangible assets	-221	-240
Disbursements due to cash investments as part of short-term financial management	-9,914	0
Proceeds from cash investments as part of short-term financial management	9,943	0
Cash flow from investing activities	-1,533	-1,413
Repayment of bank loans	-313	-312
Disbursement of long-term bank loan	0	0
Repayment of rental and lease liabilities	-724	-602
Change in other financial debt	0	0
Dividends paid	0	0
Cash flow from financing activities	-1,037	-914
Changes to cash and cash equivalents due to exchange rate fluctuations	-178	-1
Change in cash and cash equivalents	-871	700
Cash and cash equivalents at the beginning of the year	51,364	52,075
Cash and cash equivalents at the end of the period	50,493	52,775
Cash flow from operating activities includes:
Interest paid during the period	40	71
Interest received during the period	76	2
Taxes paid during the period	725	233

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (IFRS)

					Items that will not be reclassified to profit and loss		Items that will be reclassified to profit and loss in later periods
in € thousand	Subscribed capital	Additional paid-in capital	Earnings reserve	Retained earnings	Remeasurement of defined benefit plans	Deferred taxes	Foreign currency adjustment	Deferred taxes	Total shareholders' equity attributable to shareholders of SÜSS MicroTec SE
As of 01/01/2022	19,116	55,822	202	78,960	-2,469	662	4,583	-	156,876
Profit for the period				1,420					1,420
Total income and expenses recognized in shareholders' equity							519	-	519
Total comprehensive income/loss				1,420	-	-	519	-	1,939
As of 03/31/2022	19,116	55,822	202	80,380	-2,469	662	5,102	-	158,815
As of 01/01/2023	19,116	55,822	202	100,426	- 1,744	465	3,443	-	177,730
Profit for the period				2,104					2,104
Total income and expenses recognized in shareholders' equity							-810	-	-810
Dividends paid									0
Total comprehensive income/loss		0		2,104	-	-	-810	-	1,294
As of 31/03/2023	19,116	55,822	202	102,530	-1,744	465	2,633	-	179,024

Accumulated other comprehensive income

SEGMENT REPORTING (IFRS)

	Advanced Backend Solutions		Photomask Solutions		MicroOptics		Central Group Functions		Consolidation Effects		Total
in € thousand	3M / 2023	3M / 2022	3M / 2023	3M / 2022	3M / 2023	3M / 2022	3M / 2023	3M / 2022	3M / 2023	3M / 2022	3M / 2023	3M / 2022
External Sales	40,917	45,345	23,073	7,834	6,342	10,072	44	66			70,376	63,317
Internal Sales	38	80	-	2	558	515	-	-	-596	-597	-	-
Total Sales	40,955	45,425	23,073	7,836	6,900	10,587	44	66	-596	-597	70,376	63,317
Gross profit	14,867	15,895	7,021	2,070	1,430	3,070	-59	-1			23,259	21,034
Gross profit margin	36.3%	35.0%	30.4%	26.4%	20.7%	29.0%	0.0%	0.0%			33.0%	33.2%
Other segment expenses / income (net)	-14,208	-12,389	-3,358	-3,427	-2,520	-2,361	-224	-747			-20,310	-18,924
thereof intersegmen cost allocation (net)	-2,325	-2,327	-758	-389	-286	-282	3,369	2,998			-	-
thereof central services of SMT SE	-2,302	-2,262	-758	-389	-309	-301	3,369	2,952			-	-
Result per segment (EBIT)	659	3,506	3,663	-1,356	-1,090	709	-283	-749			2,949	2,110
EBIT margin	1.6%	7.7%	15.9%	-17.3%	-15.8%	6.7%					4.2%	3.3%
Income before taxes	641	3,479	3,663	-1,360	-1,098	700	-273	-840			2,933	1,979
Signifiant non-cash items	-484	-2,296	-154	-252	102	-457	75	-1			-461	-3,006
Segment assets	183,511	141,028	44,924	33,295	29,451	31,826	24,524	22,396	-6,614	-4,483	275,796	224,062
thereof goodwill	18,535	18,490	-	-	-	-	-	-			18,535	18,490
Unallocated assets	-	-									71,335	63,785
Total assets	-	-									347,131	287,847
Segment liabilities	-76,448	-59,923	-36,843	-18,068	-11,377	-9,365	-2,616	-2,593	6,614	4,483	-120,670	-85,466
Unallocated liabilities	-	-									-47,437	-43,566
Total liabilities	-	-									-168,107	-129,032
Depreciation and amortization	1,030	738	176	311	792	729	435	357			2,433	2,135
thereof scheduled	1,030	738	176	311	792	729	435	357			2,433	2,135
thereof impairment loss	-	-	-	-	-	-	-	-			-	-
Capital expenditure	363	502	134	29	794	499	271	383			1,562	1,413
Employees as of June 30	854	796	201	205	167	154	39	39			1,261	1,194

Sales				Assets (without Goodwill)
3M / 2023	3M / 2022	3M / 2023	3M / 2022	3M / 2023	3M / 2022
10,359	11,515	1,411	1,363	247,149	185,654
8,937	8,320	-	13	6,367	5,651
51,080	43,482	151	37	17,707	15,227
-	-	-	-	-13,962	-960
70,376 63,317		1,562	1,413	257,261	205,572
				Capital expenditure

FINANCIAL CALENDAR 2023

2022 Annual Report	March 31, 2023
2023 Quarterly Report (Q1)	May 11, 2023
2023 Shareholders' Meeting	May 31, 2023
2023 Interim Report	August 3, 2023
2023 Quarterly Report (Q3)	November 9, 2023

CONTACT

SÜSS MicroTec SE

Schleißheimer Strasse 90 85748 Garching, Germany Phone: +49 89 32007-100 E-mail: info@suss.com

Investor Relations Phone: +49 89 32007-151 / 161 E-mail: ir@suss.com www.suss.com

Forward-looking statements: Interim reports include forward-looking statements. Forward-looking statements do not present historical facts but include statements about expectations and the views of the management of SÜSS MicroTec SE. These statements are based on current plans, estimates, and forecasts of the Company's management. Investors should not place undue reliance on these statements. Forward-looking statements are to be understood in the context of the time at which they were made. The Company does not assume any obligation to update the forward-looking statements included in this report as a result of new information or future events. The Company's obligation to comply with its statutory responsibilities regarding information and reporting remains unaffected. Forward-looking statements always involve risks and uncertainties. A large number of factors that are described in this report could cause actual events to deviate substantially from the forward-looking statements included in this report.

www.suss.com